ARK Genomic Revolution ETF (ARKG) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
ARK Genomic Revolution ETF (ARKG): 1Y return 63.0%, Sharpe ratio 1.27, volatility 44.9%, max drawdown -27.5%. A ETF in the Equity asset class. Compare ARKG with other assets and invest through your own broker with pfolio.
ARK Genomic Revolution ETF (ARKG) Overview
- Type: ETF
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
ARKG Performance
- MTD
- Return: -8.7%, Sharpe: -3.66, Volatility: 71.9%, Max Drawdown: -13.2%
- YTD
- Return: 70.8%, Sharpe: 1.70, Volatility: 45.2%, Max Drawdown: -27.5%
- 1Y
- Return: 63.0%, Sharpe: 1.27, Volatility: 44.9%, Max Drawdown: -27.5%
- 5Y
- Return: -31.6%, Sharpe: 0.07, Volatility: 46.0%, Max Drawdown: -76.5%
- 10Y
- Return: 196.9%, Sharpe: 0.46, Volatility: 41.1%, Max Drawdown: -83.6%
Frequently Asked Questions
- What is ARK Genomic Revolution ETF (ARKG)?
- ARK Genomic Revolution ETF (ARKG) is a ETF in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does ARKG compare to other assets?
- You can compare ARKG with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in ARKG through pfolio?
- pfolio helps you build diversified portfolios that may include ARKG. You invest through your own broker — pfolio provides the analytics.